[
  {
    "ts": null,
    "headline": "MDxHealth Completes Bio Techne ExoDx Acquisition to Bolster Precision Diagnostics",
    "summary": "MDxHealth SA (NASDAQ:MDXH) is among the best fundamentally strong penny stocks to buy right now. On September 15, 2025, MDxHealth SA (NASDAQ:MDXH) announced the completion of its acquisition of Bio-Techne Corporation’s ExoDx business, including the ExoDx Prostate test. This $15 million transaction is part of the company’s plan to strengthen its precision diagnostics portfolio. Earlier […]",
    "url": "https://finnhub.io/api/news?id=193a573bacf1ca21f58b1ddcd8d666d6ff9611f0a4c7c8f3ba57811d2ae55292",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758464175,
      "headline": "MDxHealth Completes Bio Techne ExoDx Acquisition to Bolster Precision Diagnostics",
      "id": 136836778,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "MDxHealth SA (NASDAQ:MDXH) is among the best fundamentally strong penny stocks to buy right now. On September 15, 2025, MDxHealth SA (NASDAQ:MDXH) announced the completion of its acquisition of Bio-Techne Corporation’s ExoDx business, including the ExoDx Prostate test. This $15 million transaction is part of the company’s plan to strengthen its precision diagnostics portfolio. Earlier […]",
      "url": "https://finnhub.io/api/news?id=193a573bacf1ca21f58b1ddcd8d666d6ff9611f0a4c7c8f3ba57811d2ae55292"
    }
  }
]